FDA Cleared Web-Based, Sleep Study Reviewing, Editing, and Reporting Platform
Optimized for a seamless clinician experience, EnsoViewer provides clinicians with access to studies from all leading devices, from any location with internet, in one easy-to-use, interoperable, cloud-based platform.
Watch the video to discover how EnsoSleep with EnsoViewer simplifies the workflow of sleep professionals and sleep clinics.
Experience the Simplicity of One Platform for Sleep Study Reviewing, Editing, and Reporting
Fill Out Our Form To Schedule A Personalized Demo of EnsoViewer
Discover how EnsoSleep with the EnsoViewer web-based platform provides clinicians with access to all studies and devices, across all locations, in one easy-to-use, interoperable, cloud-based platform.
To see how EnsoViewer provides users with one platform to review studies, simply fill out our form and a team member will reach out soon to schedule a demo.
EnsoSleep Receives Expanded FDA Clearance for Pediatrics, EnsoViewer, Total Sleep Time (EnsoTST)
In July 2021, the FDA issued a 510(k) clearance for the artificial intelligence software platform EnsoSleep, expanding the AI’s reach to pediatric populations ages 13 and above, and for two additional products to support sleep centers in achieving their goal of providing excellent patient care, EnsoViewer and Total Sleep Time.
EnsoSleep is an FDA cleared AI-assisted sleep scoring and analysis solution that automates the scoring of studies, and reduces the time RPSGTs spend scoring. Consistent, reliable results provide clinicians with more time to expand patient care, improve outcomes and treat more patients.
EnsoTST enables the measurement of Total Sleep Time through commonly available data found in HSATs, resulting in more diagnostic accuracy for clinicians and patients.